ACHL

Achilles Therapeutics plc American Depositary Shares
ACHL

Overview Fund Activity
Delisted

ACHL was delisted on the 20th of March, 2025.

Back to rankings

32 hedge funds and large institutions have $29.4M invested in Achilles Therapeutics plc American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

Holders
32
Holders Change
+12
Holders Change %
+60%
% of All Funds
0.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
5
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
1
Ikarian Capital
Texas
$1.8M
2
VPC
2
Vestal Point Capital
New York
$1.88M
3
SC
3
Stempoint Capital
New York
$1.73M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.26M
5
BFM
5
Boothbay Fund Management
New York
$526K

Top Sellers

1
AG
1
Artal Group
Luxembourg
$944K
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
BBA
3
Baker Bros. Advisors
New York
$1.51M
4
Bank of America
4
Bank of America
North Carolina
$1.37K
5
VF
5
Virtu Financial
New York
$26K
Name Holding Trade Value Shares
Change 		Shares
Change %
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$4.39K +$4.39K +3,514 New
GRP
27
Global Retirement Partners
California
$2.5K -$1.25K -1,000 -33%
Bank of America
28
Bank of America
North Carolina
$1.37K -$26.9K -21,500 -95%
IGWM
29
ICA Group Wealth Management
Colorado
$500 +$500 +400 New
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$171 -$1.06K -852 -86%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$91 – – –
Point72 Asset Management
32
Point72 Asset Management
Connecticut
– -$1.26M -1,413,809 Closed
1
2